Enovis Corp - ENOV Net earnings per one share for the last twelve months

Enovis Corporation (ENOV) is implementing digital 3D planning for precise joint installation. The business relies on the B2B segment of clinics and surgeons, ensuring coverage of the global medtech market through rehabilitation systems. The rolling year net income per share trend confirms these positions, where 62.40 determines the current status of the parameter. Stable demand is supported by mature implant lines, which remain relevant amid an aging population.
Enovis Corp - analytical breakdowns and key metrics (ENOV)

This indicator measures the rolling annual growth rate of net earnings per share adjusted for currency fluctuations, determining the business's fundamental ability to scale profitability. The current rolling annual EPS growth rate is 62.40, reflecting the effectiveness of Enovis Corporation (ENOV) diversification between the joint reconstruction and rehabilitation equipment markets, minimizing operational risks through a balanced portfolio of medical solutions.